Salminen, A.V. ; Clemens, S.* ; García-Borreguero, D.* ; Ghorayeb, I.* ; Li, Y.* ; Manconi, M.* ; Ondo, W.* ; Rye, D.* ; Siegel, J.M.* ; Silvani, A.* ; Winkelman, J.W.* ; Allen, R.P.* ; Ferré, S.*
Consensus guidelines on the construct validity of rodent models of restless legs syndrome.
Dis. Model. Mech. 15:dmm049615 (2022)
Our understanding of the causes and natural course of restless legs syndrome (RLS) is incomplete. The lack of objective diagnostic biomarkers remains a challenge for clinical research and for the development of valid animal models. As a task force of preclinical and clinical scientists, we have previously defined face validity parameters for rodent models of RLS. In this article, we establish new guidelines for the construct validity of RLS rodent models. To do so, we first determined and agreed on the risk, and triggering factors and pathophysiological mechanisms that influence RLS expressivity. We then selected 20 items considered to have sufficient support in the literature, which we grouped by sex and genetic factors, iron-related mechanisms, electrophysiological mechanisms, dopaminergic mechanisms, exposure to medications active in the central nervous system, and others. These factors and biological mechanisms were then translated into rodent bioequivalents deemed to be most appropriate for a rodent model of RLS. We also identified parameters by which to assess and quantify these bioequivalents. Investigating these factors, both individually and in combination, will help to identify their specific roles in the expression of rodent RLS-like phenotypes, which should provide significant translational implications for the diagnosis and treatment of RLS.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Construct Validity ; Guidelines ; Restless Legs Syndrome ; Rodent Models
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
HGF-reported in Year
2022
ISSN (print) / ISBN
1754-8403
e-ISSN
1754-8411
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 15,
Issue: 8,
Pages: ,
Article Number: dmm049615
Supplement: ,
Series
Publisher
Company of Biologists
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-503200-001
Grants
National Institute on Drug Abuse
National Institutes of Health
Copyright
Erfassungsdatum
2022-11-09